A 'fit and healthy' 46-year-old mother, Cecilia Capolupo, was tragically diagnosed with terminal stage-four bowel cancer after initially experiencing what she thought were minor symptoms. Her ordeal began following a family holiday to Devon, where, upon returning, she noticed persistent bloating and stomach cramps. Originally from Argentina and residing in Clapham, London, Ms Capolupo sought medical advice, with her GP initially suspecting an infection.

However, a subsequent routine colonoscopy in September 2025 revealed the devastating truth: an eight-centimetre tumour had aggressively spread to her abdominal wall, liver, and lungs. Doctors delivered the grim prognosis that she had approximately two years left to live. Ms Capolupo described the moment as receiving a 'death sentence' on the same day as her colonoscopy, leading to a profound panic attack and intense emotional distress, waking up crying and having to communicate her impending death to friends and family.

Before her diagnosis, Ms Capolupo led an active lifestyle, regularly attending Pilates classes, cycling, and dancing, never anticipating such a severe health issue. Her symptoms, which included a 'tiny bit of red' in her stool five days after returning from holiday, did not align with typical bowel cancer signs like constipation or diarrhoea, making the diagnosis an even greater shock. She questioned how her lungs could be affected given her high level of physical activity.

Currently, Ms Capolupo is undergoing fortnightly chemotherapy sessions, supplemented by at-home treatments, in an effort to prolong her life. The rigorous treatment has taken a toll, making her feel 'like a 90-year-old lady' with the 'worst hangover of all time.' Despite the challenging prognosis, which includes a 13 per cent survival rate in five years for stage-four cancer, Ms Capolupo remains resolute. She is determined to fight, stating she is 'not planning to die any time soon,' and is committed to returning to work and her Pilates classes to continue living her life.

Her story also sheds light on the broader issue of bowel cancer screening. As the UK's third most common cancer, affecting one in 20 women and one in 15 men, there is a discrepancy in screening protocols. While Australia offers universal bowel screenings for individuals aged 45 and above, patients in England, Scotland, and Wales typically receive faecal test kits only from the age of 50. Ms Capolupo believes that had she been screened at 45, upon her first symptom, her situation would be 'much better,' underscoring the critical importance of earlier detection.